Stoke Therapeutics Inc STOK Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$26.54 up $0.47, 1.80% at close Nov 6
Last close · Previous close $26.07
- Market cap
- $1.71BAt the Nov 6 close
- P/E ratio
- On last 12 months’ EPS
- Diluted EPS
- Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$26.54up $0.47, 1.80%Fri, Nov 6 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$26.07Nov 5
- Volume1.16MNov 6 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume1.35MLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $21.81 to $40.22; now $26.54
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 6 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
STOK beat the S&P 500 in 3 of 6 periods.
| Period | STOK and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | STOK: up 8.9% S&P 500: down 5.6% | STOK beat the S&P 500 by 14.5 percentage points Beat |
| 3M | STOK: down 16.9% S&P 500: down 4.1% | STOK trailed the S&P 500 by 12.8 percentage points Trailed |
| YTD | STOK: down 16.4% S&P 500: up 8.7% | STOK trailed the S&P 500 by 25.1 percentage points Trailed |
| 1Y | STOK: up 18.1% S&P 500: up 10.9% | STOK beat the S&P 500 by 7.2 percentage points Beat |
| Long term | ||
| 3Y | STOK: up 515.8% S&P 500: up 75.0% +83.3% vs +20.5% a year | STOK beat the S&P 500 by 440.8 percentage points Beat |
| 5Y | STOK: up 2.2% S&P 500: up 67.8% +0.4% vs +10.9% a year | STOK trailed the S&P 500 by 65.6 percentage points Trailed |
$10,000 invested in STOK 5 years ago (Nov 5, 2021) would be worth about $10,219 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $16,782.
STOK beat the S&P 500 in 3 of 6 periods.
| Period | STOK and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | STOK: up 8.9% S&P 500: down 5.6% | STOK beat the S&P 500 by 14.5 percentage points Beat |
| 3M | STOK: down 16.9% S&P 500: down 4.3% | STOK trailed the S&P 500 by 12.6 percentage points Trailed |
| YTD | STOK: down 16.4% S&P 500: up 7.8% | STOK trailed the S&P 500 by 24.2 percentage points Trailed |
| 1Y | STOK: up 18.1% S&P 500: up 9.7% | STOK beat the S&P 500 by 8.4 percentage points Beat |
| Long term | ||
| 3Y | STOK: up 515.8% S&P 500: up 68.8% +83.3% vs +19.1% a year | STOK beat the S&P 500 by 447.0 percentage points Beat |
| 5Y | STOK: up 2.2% S&P 500: up 56.9% +0.4% vs +9.4% a year | STOK trailed the S&P 500 by 54.7 percentage points Trailed |
$10,000 invested in STOK 5 years ago (Nov 5, 2021) would be worth about $10,219 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $15,694.
All-time high
$69.81
Closing high on . Now 62.0% below that record.
Split-adjusted daily closes since Jun 19, 2019.
Stock splits
STOK hasn’t split since its price history begins in 2019.
Valuation
Financials
About Stoke Therapeutics Inc
Stoke Therapeutics Inc
- Sector
- Industry
- Headquarters
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
STOK news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
STOK stock FAQ
What is STOK stock’s price today?
Stoke Therapeutics (STOK) traded at $26.54 at the close on , up $0.47 (1.80%) from the previous close of $26.07. Over the past 52 weeks it has traded between $21.81 and $40.22.
If you invested $1,000 in STOK 5 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in STOK on would be worth about $1,022 at the close on , a total return of +2.2%. The same $1,000 would be worth $1,181 if invested one year ago. Past performance doesn’t predict future returns.
What is Stoke Therapeutics’s market cap?
Stoke Therapeutics’s market capitalization is about $1.7 billion. That’s Tiingo’s daily market cap for , at that day’s closing price of $26.54 (how market cap works).
Does STOK pay a dividend?
Stoke Therapeutics hasn’t paid a dividend in the last twelve months.
What is STOK’s 52-week high and low?
Over the past 52 weeks STOK has traded as low as $21.81 and as high as $40.22. At $26.54 at the close on , it is 34.0% below that high and 21.7% above the low.
What is STOK’s all-time high?
STOK’s highest closing price was $69.81 on , adjusted for stock splits. At $26.54 at the close on , it is 62.0% below that record.
Has STOK stock ever split?
No. STOK hasn’t split since its price history begins in 2019.
How has STOK stock performed?
Including dividends and measured to the close on , STOK has returned −16.4% so far this year and +18.1% over the past year, and +2.2% over five years (+0.4% a year). Over the same periods the S&P 500, measured by SPY, returned +8.7%, +10.9% and +67.8%. Past performance doesn’t predict future returns.
What exchange does STOK trade on?
Stoke Therapeutics trades on the Nasdaq under the ticker symbol STOK. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.